These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 5800804)
1. [Study of trypsin and chymotrypsin inhibiting capacity of the serum. Its pathological variations]. Warter J; Métais P; Bieth J Rev Fr Etud Clin Biol; 1969 May; 14(5):466-71. PubMed ID: 5800804 [No Abstract] [Full Text] [Related]
2. Proteinase inhibition in plasma during experimental acute rat pancreatitis. Huttunen R Ann Med Exp Biol Fenn; 1973; 51(4):139-44. PubMed ID: 4787807 [No Abstract] [Full Text] [Related]
3. Pancreatic enzyme inhibitors in health and disease. Maneche HC; Paul TM; Kahn DS Am J Clin Pathol; 1971 Apr; 55(4):458-64. PubMed ID: 5554199 [No Abstract] [Full Text] [Related]
4. [On the determination of trypsin and chymotrypsin inhibitor capacity in human serum]. Freimuth U; Büchner M; Fordran J Z Med Labortech; 1968; 9(6):361-4. PubMed ID: 5730747 [No Abstract] [Full Text] [Related]
5. [Trypsin- and chymotrypsin-inhibiting capacity of the serum in bullous pemphigoid]. Lohrisch I; Duck HJ; Herrmann K; Haustein UF Dermatol Monatsschr; 1980 Nov; 166(11):755-6. PubMed ID: 7007116 [No Abstract] [Full Text] [Related]
6. [Study of protease inhibition by ascitic and pleural fluids: comparative determinations of alpha-1-antitrypsin, alpha-2-macroglobulin and protease inhibition capacity]. Bieth J; Miesch F; Métais P Ann Biol Clin (Paris); 1971; 29(1):51-8. PubMed ID: 5579075 [No Abstract] [Full Text] [Related]
12. Plasma trypsin-like immunoreactivity in normal subjects and in patients with pancreatic diseases. Adrian TE Scand J Gastroenterol Suppl; 1980; 62():15-20. PubMed ID: 6935750 [No Abstract] [Full Text] [Related]
13. New trypsin- and chymotrypsin-binding factor in rat plasma. Huttunen R; Korhonen LK Ann Med Exp Biol Fenn; 1973; 51(4):145-50. PubMed ID: 4799134 [No Abstract] [Full Text] [Related]
14. [Parallels in changes in enterokinase and trypsin activity in patients with chronic diseases of the liver and pancreas]. Valenkevich LN; Iakhontova OI Vrach Delo; 1969 Oct; 10():13-5. PubMed ID: 5366790 [No Abstract] [Full Text] [Related]
15. [Activity of lactate dehydrogenase and its isoenzymes in the blood serum in diseases of the hepatobiliary system]. Riaposova IK Voen Med Zh; 1971 Sep; 9():73-4. PubMed ID: 5129155 [No Abstract] [Full Text] [Related]
16. [Application of Laurell's method of electro-immunodiffusion to the determination of some serum proteins]. Miesch F; Bieth J; Métais P Ann Biol Clin (Paris); 1968; 26(7):939-48. PubMed ID: 5727317 [No Abstract] [Full Text] [Related]
18. [The glycoamylasemic curve in pancreatic semiology]. Meschino S; Giovannelli G; Barducci O Atti Accad Fisiocrit Siena Med Fis; 1967; 16(1):875-87. PubMed ID: 5621935 [No Abstract] [Full Text] [Related]
19. Experimental biliary pancreatitis in dogs. VI. Effect of proteinase inhibitors and stabilizers of dog serum fractions on the pancreatitic and commercial proteinases. Herva P; Forsén R; Raunio V Scand J Gastroenterol Suppl; 1970; 8():53-60. PubMed ID: 5273577 [No Abstract] [Full Text] [Related]
20. Serum immunoreactive trypsin and trypsin inhibitors during acute pancreatitis. Mero M; Tenhunen R; Pessi T; Sandholm M Ann Chir Gynaecol; 1980; 69(6):251-5. PubMed ID: 6163388 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]